
Tuesday, February 14, 2023 12:30:55 PM
Recent OCUL News
- Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/07/2025 09:05:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/03/2025 12:19:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2025 12:07:02 PM
- Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2024 Results and Business Highlights • GlobeNewswire Inc. • 03/03/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2025 11:27:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2025 11:24:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2025 11:22:06 PM
- Ocular Therapeutix™ to Present at Two Investor Conferences in March • GlobeNewswire Inc. • 02/25/2025 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/24/2025 09:54:17 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/24/2025 09:33:36 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/24/2025 09:32:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/24/2025 09:30:09 PM
- Ocular Therapeutix™ to Report Fourth Quarter and Full Year 2024 Results on March 3, 2025 • GlobeNewswire Inc. • 02/24/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2025 12:32:26 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/14/2025 11:46:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2025 01:38:44 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2025 01:37:32 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2025 01:36:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2025 01:35:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2025 12:16:20 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/04/2025 09:24:07 PM
- Ocular Therapeutix™ Announces Upcoming Presentations at the Angiogenesis, Exudation, and Degeneration 2025 Virtual Meeting • GlobeNewswire Inc. • 02/03/2025 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/31/2025 09:24:29 PM
- Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 01/17/2025 12:00:00 PM
- Ocular Therapeutix™ Shares SOL-R Enrollment Progress and Next Steps for AXPAXLI™ in NPDR • GlobeNewswire Inc. • 01/14/2025 12:00:00 PM
One World Products' Isiah Thomas Issues Investor Update • OWPC • Mar 6, 2025 9:19 AM
Authentic Holdings To Reduce Debt by over $2 Million While Achieving Substantial Revenue Growth • AHRO • Mar 6, 2025 8:00 AM
Nightfood Holdings, Inc. (NGTF) Signs Letter of Intent to Acquire Skytech Automated Solutions Inc. to Expand AI-Powered Robotics Portfolio • NGTF • Mar 5, 2025 8:44 AM
North Bay Resources Announces Refinery Shipment of Gold Concentrate from Bishop Gold Mill • NBRI • Mar 4, 2025 9:00 AM
UAV Corp. Secures LOI for Multi-Unit Purchase of DART 600 Airship Systems • UMAV • Mar 4, 2025 8:30 AM
UCASU Expected to Report $0.02/share Net Profit for 2024 • UCASU • Mar 3, 2025 1:55 PM